Patents by Inventor Martin R. Schiller

Martin R. Schiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12385069
    Abstract: Disclosed are compositions and methods for studying a Tat gene. Specifically, the disclosure provides a vector comprising a double-stranded nucleic acid construct which comprises a Tat gene and a green fluorescent protein (GFP) reporter element, and further wherein the double-stranded nucleic acid construct comprising AAVS1 (adeno-associated virus integration site, a safe harbor locus) arms that flank on both sides of the Tat gene and the reporter element for integration at the human AAVS1 site by homologus recombination. Further provided are methods of using a cell comprising the vector for studying the effects of exogenous conditions on expression of the Tat gene.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: August 12, 2025
    Assignee: The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University of Nevada
    Inventors: Martin R. Schiller, Ronald Benjamin
  • Publication number: 20240347133
    Abstract: The invention of the present disclosure relates to methods of analyzing results of a high-throughput assay system for molecular functions and cell processes, comprising generation of a plasmid cDNA library for a gene of interest, conversion of the plasmid cDNA library into a lentiviral library, engineering of a cell line to encode a reporter assay to measure a specific molecular function or cell process, providing a population of cells, each cell comprising a gene of interest and an engineered reporter element, sorting the population of cells into a plurality of pools, performing targeted next-generation sequencing for the integrated gene cDNA and barcode to generate a plurality of paired end reads for each cell-sorted pool, and performing a bioinformatics analysis to determine the affect each mutation in the protein of interest has on its measured function.
    Type: Application
    Filed: January 5, 2024
    Publication date: October 17, 2024
    Inventors: Martin R. SCHILLER, Christopher GIACOLETTO
  • Patent number: 11046959
    Abstract: Disclosed herein, are compositions and methods for the treatment of human immunodeficiency virus infection. The compositions comprise engineered transcription activator like effector nucleases (TALENs) comprising a TALE DNA binding domain flanked by two spacer sequences, and a Fokl nuclease catalytic domain. Also, described herein, are methods of using TALENs to cleave nucleic acids; and methods of administering the TALENs to subjects at risk for or having an HIV infection.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: June 29, 2021
    Assignee: The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas
    Inventors: Martin R. Schiller, Christy L. Strong
  • Publication number: 20200017883
    Abstract: Disclosed are compositions and methods for studying a Tat gene. Specifically, the disclosure provides a vector comprising a double-stranded nucleic acid construct which comprises a Tat gene and a green fluorescent protein (GFP) reporter element, and further wherein the double-stranded nucleic acid construct comprising AAVS1 (adeno-associated virus integration site, a safe harbor locus) arms that flank on both sides of the Tat gene and the reporter element for integration at the human AAVS1 site by homologus recombination. Further provided are methods of using a cell comprising the vector for studying the effects of exogenous conditions on expression of the Tat gene.
    Type: Application
    Filed: July 14, 2017
    Publication date: January 16, 2020
    Applicant: The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University of Nevada
    Inventors: Martin R. Schiller, Ronald Benjamin
  • Publication number: 20180112219
    Abstract: Disclosed herein, are compositions and methods for the treatment of human immunodeficiency virus infection. The compositions comprise engineered transcription activator like effector nucleases (TALENs) comprising a TALE DNA binding domain flanked by two spacer sequences, and a Fold nuclease catalytic domain. Also, described herein, are methods of using TALENs to cleave nucleic acids; and methods of administering the TALENs to subjects at risk for or having an HIV infection.
    Type: Application
    Filed: March 30, 2016
    Publication date: April 26, 2018
    Inventors: Martin R. Schiller, Christy L. Strong
  • Publication number: 20170335316
    Abstract: Disclosed herein are novel compositions and methods for elucidating biological activity and detection of molecular function. The methods and compositions disclosed herein can comprise the use of one or more minimotifs and a minimotif database for integrating and coordinating orthogonal knowledge derived from a variety of technological endeavors to provide systemic models representing complex biological and molecular interactions ranging from individual cells to entire organisms. The methods and compositions disclosed herein can utilize information related to biometrics including protein/protein interaction, and gene/gene interaction for evaluating cellular functions and cellular mechanisms.
    Type: Application
    Filed: October 19, 2015
    Publication date: November 23, 2017
    Inventors: Martin R. Schiller, Christy L. Strong